Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
33%
Ph phase_1
1
33%
Ph not_applicable
1
33%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Terminated(1)
Other(1)

Detailed Status

unknown1
Withdrawn1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (33.3%)
Phase 31 (33.3%)
N/A1 (33.3%)

Trials by Status

unknown133%
withdrawn133%
completed133%

Recent Activity

0 active trials
Showing 3 of 3
withdrawnphase_1

Comparing Two Treatments That Both Target Smoking Cessation and Weight Loss at the Same Time.

NCT04130698
unknownnot_applicable

Emotion Regulation Interventions for Preventing Collegiate Escalations in Drinking

NCT04492982
completedphase_3

Distress Tolerance and Buprenorphine

NCT01556087

Clinical Trials (3)

Showing 3 of 3 trials
NCT04130698Phase 1

Comparing Two Treatments That Both Target Smoking Cessation and Weight Loss at the Same Time.

Withdrawn
NCT04492982Not Applicable

Emotion Regulation Interventions for Preventing Collegiate Escalations in Drinking

Unknown
NCT01556087Phase 3

Distress Tolerance and Buprenorphine

Completed

All 3 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
3